Chest infection Flashcards
What are the principles of treatment?
Consider pathogen, host (immune system) and severity
What are the two bacterias most associated with pneumonia?
Haemophilus influenza
Streptococcus pneumoniae
What is septic shock?
Subset of patients with profound circulatory, cellular and metabolic abnormalities
MAP <65mmHg, lactate >2mmol/l
Hypotension despite fluid resuscitation, requiring vasopressors
Consider sepsis alongside consideration of pneumonia and antibiotics
URTI tx
Supportive, not antibiotics
Special diagnoses - stridor, croup, quinsy
Consider underlying diagnosis - allergy, polyps, immunity
Consider ENT review and direct nasendoscopy
LRTI tx
Supportive, aybe antibiotics
Consider related morbidity - asthma, chronic cough
Make a back-up plan - consider CXR, antibiotics, referral
Pneumonia tx
Consolidation on chest imaging
Supportive and antibiotics (normally even if viral cause)
Decisions on AB choice (spectrum) and duration (5-7-10 days)
Consider underlying diagnoses - allergy, polyps, immunity, co-morbities, bronchiectasis, COPD
Consider admission
Empyema
Collection of fluid in pleural cavity caused by MO’s
Definitely antibiotics and definitely drain
Supportive - co-morbidities, pyscho-social, pin, oxygen
Consider underlying diagnosis - pathogen, immunity, surgery
Bronchiectasis
Widening of the airways, causing more mucous build up, more likely to have infection - common symptom is a persistent cough with phlegm
Airway clearance and antibiotics
Long term chronic lung disease, management plan, specialist nurses, rescue therapies etc
Lung abscess, cavitation
Definitely antibiotics, tx defined by cause
Identify pathogen, surgery, antibiotics
Pneumonia (pathology, symptoms and signs, prognosis)
Pathology - consolidation, pus/necrosis
S and S - cough and phlegm, SOB, fever
Prognosis - consider CRB65, consider CAP/HAP
HAP
Included more than 48h after admission or within 10-30 days of discharge
Radiographic change - pneumonia, effusion, empyema
ALtered microbiological context - gram -ve, anaerobes, MRSA (C.difficile)
Follow-up goals
Consider exclusion of other diagnoses, exclusion of residual infection, complications of infection
Consider pneumonia vs bronchiectasis vs pleural infection control
Post pneumonia CXR - cancer, residual infection or complication
Future directions
rapid diagnostics rapid drug sensitivities improved community support Immunomodulatory therapy Biomarkers to assess response (7 day course)
Sequencing
Whole genome sequencing
Cost, speed, logistics
Bioinformatics
Clinical utility